is the first Russian venture fund fully dedicated to investments in the life sciences sector.
The fund has been created with the participation of the Russian Venture Capital (RVC), a government-sponsored fund of funds that has a mission of promoting the development of innovation-based economy in the country. Maxwell Biotech Venture Fund is managed by one of the leading Russian financial firms, Maxwell Asset Management, that has engaged a dedicated team of professionals with decades of experience in healthcare, biotechnology and investment banking industry. In addition, the fund partners with the Maxwell Biotech Group in making portfolio investments, and a list of the fund's current investments can be found in Our Portfolio. Maxwell Biotech Venture Fund has offices in Moscow, Russia and Boston, USA.